Clinical Trial 7571

Imperial, CA 92251

Study Summary:

A long-term, open-label, safety study of Eszopiclone in children (6 to 11 years) and adolescents (12 to 17 years) with attention deficit/hyperactivity disorder-associated insomnia.

Qualified Participants Must:

• Be 6-17 years of age
• Have been diagnosed with ADHD
• Have complaints of insomnia
• Be in good general health

Qualified Participants May Receive:

You may qualify to receive up to $35 for your time and travel per visit. You receive no-cost study-related medication and study-related medical care.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.